| pubmed-article:10651518 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10651518 | lifeskim:mentions | umls-concept:C0005574 | lld:lifeskim |
| pubmed-article:10651518 | lifeskim:mentions | umls-concept:C0162557 | lld:lifeskim |
| pubmed-article:10651518 | pubmed:issue | 3 Suppl 3 | lld:pubmed |
| pubmed-article:10651518 | pubmed:dateCreated | 2000-1-24 | lld:pubmed |
| pubmed-article:10651518 | pubmed:abstractText | Orthotopic liver transplantation survival for patients with acute liver failure is poor (50%). Mortality on the waiting list is high due to the lack of donors. For these reasons, the possibility of sustaining hepatic function by extra-corporeal liver perfusion must be considered. In this experimental research, two groups of pigs have been submitted to total de-vascularisation of the liver causing acute hepatic failure. In the first group (4 pigs) no extra-corporeal assistance has been used after total de-vascularisation. All pigs died between 16 and 33 hours after the acute hepatic failure was induced. In the second group (8 pigs) after complete hepatic de-vascularisation an extra-corporeal hepatic support by continuous allo-perfusion of isolated liver was performed using the Abouna-Costa extra-corporeal circuit. All pigs were observed during the acute hepatic failure which lasted from 6.30 to 7.30 hours. The data that were more positively influenced by the extra-corporeal assistance were ammonia and lactates that improved after the application of hepatic assistance. | lld:pubmed |
| pubmed-article:10651518 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10651518 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10651518 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10651518 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10651518 | pubmed:issn | 1121-8142 | lld:pubmed |
| pubmed-article:10651518 | pubmed:author | pubmed-author:RossiGG | lld:pubmed |
| pubmed-article:10651518 | pubmed:author | pubmed-author:GattoII | lld:pubmed |
| pubmed-article:10651518 | pubmed:author | pubmed-author:FassatiL RLR | lld:pubmed |
| pubmed-article:10651518 | pubmed:author | pubmed-author:PratoPP | lld:pubmed |
| pubmed-article:10651518 | pubmed:author | pubmed-author:LathamLL | lld:pubmed |
| pubmed-article:10651518 | pubmed:author | pubmed-author:CaccamoLL | lld:pubmed |
| pubmed-article:10651518 | pubmed:author | pubmed-author:GiammarinaroG... | lld:pubmed |
| pubmed-article:10651518 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10651518 | pubmed:volume | 9 | lld:pubmed |
| pubmed-article:10651518 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10651518 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10651518 | pubmed:pagination | 67-73 | lld:pubmed |
| pubmed-article:10651518 | pubmed:dateRevised | 2003-11-14 | lld:pubmed |
| pubmed-article:10651518 | pubmed:meshHeading | pubmed-meshheading:10651518... | lld:pubmed |
| pubmed-article:10651518 | pubmed:meshHeading | pubmed-meshheading:10651518... | lld:pubmed |
| pubmed-article:10651518 | pubmed:meshHeading | pubmed-meshheading:10651518... | lld:pubmed |
| pubmed-article:10651518 | pubmed:meshHeading | pubmed-meshheading:10651518... | lld:pubmed |
| pubmed-article:10651518 | pubmed:meshHeading | pubmed-meshheading:10651518... | lld:pubmed |
| pubmed-article:10651518 | pubmed:articleTitle | Biotechnologies and acute hepatic failure. | lld:pubmed |
| pubmed-article:10651518 | pubmed:affiliation | Istituto di Chirurgia Sperimentale e dei Trapianti, Università di Milano, Unità Operativa per il Trapianto e la Chirurgia del Fegato e del Polmone, Ospedale Maggiore IRCCS, Milano. | lld:pubmed |
| pubmed-article:10651518 | pubmed:publicationType | Journal Article | lld:pubmed |
